Literature DB >> 30197820

Mining FDA resources to compute population-specific frequencies of adverse drug reactions.

Aleksandar Poleksic1, Carson Turner1, Rishabh Dalal1, Paul Gray1, Lei Xie2.   

Abstract

Adverse drug reactions (ADRs) represent one of the main health and economic problems in the world. With increasing data on ADRs, there is an increased need for software tools capable of organizing and storing the information on drug-ADR associations in a form that is easy to use and understand. Here we present a step by step computational procedure capable of extracting drug-ADR frequency data from the large collection of patient safety reports stored in the Federal Drug Administration database. Our procedure is the first of its type capable of generating population specific drug-ADR frequencies. The drug-ADR data generated by our method can be made specific to a single patient population group (such as gender or age) or a single therapy characteristic (such as drug dosage, duration of therapy) or any combination of such.

Entities:  

Keywords:  ADR; FDA; adverse drug reaction; case report; side-effect

Year:  2017        PMID: 30197820      PMCID: PMC6128702          DOI: 10.1109/BIBM.2017.8217935

Source DB:  PubMed          Journal:  Proceedings (IEEE Int Conf Bioinformatics Biomed)        ISSN: 2156-1125


  17 in total

1.  An overview of MetaMap: historical perspective and recent advances.

Authors:  Alan R Aronson; François-Michel Lang
Journal:  J Am Med Inform Assoc       Date:  2010 May-Jun       Impact factor: 4.497

2.  Adverse drug reactions and polypharmacy in the elderly in general practice.

Authors:  L J Veehof; R E Stewart; B Meyboom-de Jong; F M Haaijer-Ruskamp
Journal:  Eur J Clin Pharmacol       Date:  1999-09       Impact factor: 2.953

Review 3.  Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.

Authors:  P Impicciatore; I Choonara; A Clarkson; D Provasi; C Pandolfini; M Bonati
Journal:  Br J Clin Pharmacol       Date:  2001-07       Impact factor: 4.335

4.  Medication use leading to emergency department visits for adverse drug events in older adults.

Authors:  Daniel S Budnitz; Nadine Shehab; Scott R Kegler; Chesley L Richards
Journal:  Ann Intern Med       Date:  2007-12-04       Impact factor: 25.391

Review 5.  Epidemiology of adverse drug reactions in Europe: a review of recent observational studies.

Authors:  Jacoline C Bouvy; Marie L De Bruin; Marc A Koopmanschap
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.606

6.  A side effect resource to capture phenotypic effects of drugs.

Authors:  Michael Kuhn; Monica Campillos; Ivica Letunic; Lars Juhl Jensen; Peer Bork
Journal:  Mol Syst Biol       Date:  2010-01-19       Impact factor: 11.429

7.  Relating drug-protein interaction network with drug side effects.

Authors:  Sayaka Mizutani; Edouard Pauwels; Véronique Stoven; Susumu Goto; Yoshihiro Yamanishi
Journal:  Bioinformatics       Date:  2012-09-15       Impact factor: 6.937

8.  Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study.

Authors:  K J Patel; M S Kedia; D Bajpai; S S Mehta; N A Kshirsagar; N J Gogtay
Journal:  BMC Clin Pharmacol       Date:  2007-07-28

Review 9.  Clinical and economic burden of adverse drug reactions.

Authors:  Janet Sultana; Paola Cutroneo; Gianluca Trifirò
Journal:  J Pharmacol Pharmacother       Date:  2013-12

10.  Predicting serious rare adverse reactions of novel chemicals.

Authors:  Aleksandar Poleksic; Lei Xie
Journal:  Bioinformatics       Date:  2018-08-15       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.